scispace - formally typeset
Open AccessJournal ArticleDOI

Effective Inhibition of HBV Replication in Vivo by Anti-HBx Short Hairpin RNAs

TLDR
Observations indicate that U6 shRNA 5 and U6ShRNAs 6 are promising candidates for therapy of chronic HBV infection.
About
This article is published in Molecular Therapy.The article was published on 2006-02-01 and is currently open access. It has received 113 citations till now. The article focuses on the topics: Small hairpin RNA & Hepatitis B virus.

read more

Citations
More filters
Journal ArticleDOI

Hydrodynamic gene delivery: its principles and applications.

TL;DR: This review provides an overview of the theory and practice of hydrodynamic gene delivery so as to aid researchers for the use of this method in their pre-clinical and translational gene therapy studies.
Journal ArticleDOI

miR-122, a paradigm for the role of microRNAs in the liver

TL;DR: The biology of the most abundant miRNA in human liver, miR-122, is reviewed, and the diversity of its roles in the liver is considered, and some possible therapeutic opportunities for exploiting miRNAs in the different settings of liver diseases are considered.
Journal ArticleDOI

RNAi for Treating Hepatitis B Viral Infection

TL;DR: Several strategies for improving the anti-HBV therapeutic efficacy of siRNAs, while avoiding their off-target effects and immunostimulation are discussed.
Journal ArticleDOI

Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.

TL;DR: A new hepatotropic nontoxic lipid-based vector system that is used to deliver chemically unmodified small interfering RNA (siRNA) sequences to the liver and repeated systemic administration of triggered PEGylated siRNA-nanoparticles to HBV transgenic mice results in the suppression of markers of HBV replication by up to 3-fold relative to controls over a 28 day period.
Journal ArticleDOI

Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo

TL;DR: An approach that allows the use of a Pol II promoter to improve transcription regulation of expressed RNAi effecters is reported, and Employing Pol II-expressed pri-miR mimics may be useful in the treatment of HBV infection, and potentially also for generic application in RNAi-based therapy.
References
More filters
Journal ArticleDOI

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

TL;DR: 21-nucleotide siRNA duplexes provide a new tool for studying gene function in mammalian cells and may eventually be used as gene-specific therapeutics.
Journal ArticleDOI

A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

TL;DR: It is shown that siRNA expression mediated by this vector causes efficient and specific down-regulation of gene expression, resulting in functional inactivation of the targeted genes.
Journal ArticleDOI

RNA interference is mediated by 21- and 22-nucleotide RNAs

TL;DR: In this article, the authors demonstrate that 21 and 22-nt RNA fragments are the sequence-specific mediators of RNA interference in a Drosophila in vitro system, and provide evidence that the direction of dsRNA processing determines whether sense or antisense target RNA can be cleaved by the siRNA-protein complex.
PatentDOI

A simplified system for generating recombinant adenoviruses

TL;DR: In this paper, a recombinant adenoviral plasmid is generated with a minimum of enzymatic manipulations, employing homologous recombination in bacteria rather than in eucaryotic cells.
Journal ArticleDOI

An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells

TL;DR: It is shown that ‘loss-of-function’ phenotypes can be created in cultured Drosophila cells by transfection with specific double-stranded RNAs, which coincides with a marked reduction in the level of cognate cellular messenger RNAs.
Related Papers (5)